Idorsia Ltd - Asset Resilience Ratio

Latest as of September 2025: 1.63%

Idorsia Ltd (IDIA) has an Asset Resilience Ratio of 1.63% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check IDIA capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CHF7.39 Million

≈ $9.35 Million USD Cash + Short-term Investments

Total Assets

CHF454.57 Million

≈ $574.70 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Idorsia Ltd's Asset Resilience Ratio has changed over time. See IDIA equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Idorsia Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Idorsia Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CHF0.00	0%
Short-term Investments	CHF7.39 Million	1.63%
Total Liquid Assets	CHF7.39 Million	1.63%

Asset Resilience Insights

Limited Liquidity: Idorsia Ltd maintains only 1.63% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Idorsia Ltd Industry Peers by Asset Resilience Ratio

Compare Idorsia Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	10.93%
CSL Ltd AU:CSL	Biotechnology	0.41%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	57.90%
HLB Co. Ltd KQ:028300	Biotechnology	0.72%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
MBX Biosciences, Inc. Common Stock NASDAQ:MBX	Biotechnology	87.20%
Tourmaline Bio Inc. NASDAQ:TRML	Biotechnology	77.17%
PharmaResources (Shanghai) Co. Ltd. A SHE:301230	Biotechnology	16.35%

Annual Asset Resilience Ratio for Idorsia Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Idorsia Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	3.55%	CHF17.98 Million ≈ $22.73 Million	CHF505.89 Million ≈ $639.59 Million	+1.00pp
2023-12-31	2.55%	CHF12.76 Million ≈ $16.14 Million	CHF500.00 Million ≈ $632.13 Million	-33.98pp
2022-12-31	36.53%	CHF330.33 Million ≈ $417.62 Million	CHF904.18 Million ≈ $1.14 Billion	-26.64pp
2021-12-31	63.17%	CHF936.77 Million ≈ $1.18 Billion	CHF1.48 Billion ≈ $1.87 Billion	-0.87pp
2020-12-31	64.04%	CHF919.22 Million ≈ $1.16 Billion	CHF1.44 Billion ≈ $1.81 Billion	-9.96pp
2019-12-31	74.00%	CHF743.07 Million ≈ $939.44 Million	CHF1.00 Billion ≈ $1.27 Billion	+8.34pp
2018-12-31	65.66%	CHF923.67 Million ≈ $1.17 Billion	CHF1.41 Billion ≈ $1.78 Billion	+0.58pp
2017-12-31	65.08%	CHF840.75 Million ≈ $1.06 Billion	CHF1.29 Billion ≈ $1.63 Billion	-14.47pp
2016-12-31	79.55%	CHF727.98 Million ≈ $920.36 Million	CHF915.12 Million ≈ $1.16 Billion	--

pp = percentage points

About Idorsia Ltd

SW:IDIA Switzerland Biotechnology

Market Cap

$1.45 Billion

CHF1.14 Billion CHF

Market Cap Rank

#8973 Global

#119 in Switzerland

Share Price

CHF4.51

Change (1 day)

-3.10%

52-Week Range

CHF1.87 - CHF4.79

All Time High

CHF33.62